Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

103 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
miR-126 identifies a quiescent and chemo-resistant human B-ALL cell subset that correlates with minimal residual disease.
Caserta C, Nucera S, Barcella M, Fazio G, Naldini MM, Pagani R, Pavesi F, Desantis G, Zonari E, D'Angiò M, Capasso P, Lombardo A, Merelli I, Spinelli O, Rambaldi A, Ciceri F, Silvestri D, Valsecchi MG, Biondi A, Cazzaniga G, Gentner B. Caserta C, et al. Leukemia. 2023 Oct;37(10):1994-2005. doi: 10.1038/s41375-023-02009-5. Epub 2023 Aug 28. Leukemia. 2023. PMID: 37640845
Detection of PICALM-MLLT10 (CALM-AF10) and outcome in children with T-lineage acute lymphoblastic leukemia.
Lo Nigro L, Mirabile E, Tumino M, Caserta C, Cazzaniga G, Rizzari C, Silvestri D, Buldini B, Barisone E, Casale F, Luciani M, Locatelli F, Messina C, Micalizzi C, Pession A, Parasole R, Santoro N, Masera G, Basso G, Aricò M, Valsecchi M, Biondi A, Conter V; AIEOP—Scientific Committee of ALL. Lo Nigro L, et al. Among authors: caserta c. Leukemia. 2013 Dec;27(12):2419-21. doi: 10.1038/leu.2013.149. Epub 2013 May 14. Leukemia. 2013. PMID: 23670296 No abstract available.
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.
Mucci A, Antonarelli G, Caserta C, Vittoria FM, Desantis G, Pagani R, Greco B, Casucci M, Escobar G, Passerini L, Lachmann N, Sanvito F, Barcella M, Merelli I, Naldini L, Gentner B. Mucci A, et al. Among authors: caserta c. EMBO Mol Med. 2021 Oct 7;13(10):e13598. doi: 10.15252/emmm.202013598. Epub 2021 Aug 30. EMBO Mol Med. 2021. PMID: 34459560 Free PMC article.
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia.
Naldini MM, Casirati G, Barcella M, Rancoita PMV, Cosentino A, Caserta C, Pavesi F, Zonari E, Desantis G, Gilioli D, Carrabba MG, Vago L, Bernardi M, Di Micco R, Di Serio C, Merelli I, Volpin M, Montini E, Ciceri F, Gentner B. Naldini MM, et al. Among authors: caserta c. Nat Commun. 2023 Mar 8;14(1):1285. doi: 10.1038/s41467-023-36969-0. Nat Commun. 2023. PMID: 36890137 Free PMC article.
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia.
Magliulo D, Simoni M, Caserta C, Fracassi C, Belluschi S, Giannetti K, Pini R, Zapparoli E, Beretta S, Uggè M, Draghi E, Rossari F, Coltella N, Tresoldi C, Morelli MJ, Di Micco R, Gentner B, Vago L, Bernardi R. Magliulo D, et al. Among authors: caserta c. EMBO Mol Med. 2023 Nov 8;15(11):e17810. doi: 10.15252/emmm.202317810. Epub 2023 Oct 9. EMBO Mol Med. 2023. PMID: 37807875 Free PMC article.
Efficacy and Safety of Pembrolizumab plus Axitinib combination for Metastatic Renal Cell Carcinoma in a Real-World Scenario: Data From the Prospective ProPAXI Study.
Guida A, Gili A, Mosillo C, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Fornarini G, Rebuzzi SE, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S. Guida A, et al. Among authors: caserta c. Clin Genitourin Cancer. 2024 Dec;22(6):102225. doi: 10.1016/j.clgc.2024.102225. Epub 2024 Sep 14. Clin Genitourin Cancer. 2024. PMID: 39405768
Utility of waist-to-height ratio, waist circumference and body mass index in predicting clustered cardiometabolic risk factors and subclinical vascular phenotypes in children and adolescents: A pooled analysis of individual data from 14 countries.
Zong X, Kelishadi R, Kim HS, Schwandt P, Matsha TE, Mill JG, Whincup PH, Pacifico L, López-Bermejo A, Caserta CA, Medeiros CCM, Yan WL, Kollias A, Skidmore P, Correia-Costa L, Khadilkar A, Jazi FS, Gong Z, Zhang C, Magnussen CG, Zhao M, Xi B. Zong X, et al. Among authors: caserta ca. Diabetes Metab Syndr. 2024 May;18(5):103042. doi: 10.1016/j.dsx.2024.103042. Epub 2024 May 17. Diabetes Metab Syndr. 2024. PMID: 38781718
REGOMA-OSS: a large, Italian, multicenter, prospective, observational study evaluating the efficacy and safety of regorafenib in patients with recurrent glioblastoma.
Caccese M, Desideri I, Villani V, Simonelli M, Buglione M, Chiesa S, Franceschi E, Gaviani P, Stasi I, Caserta C, Brugnara S, Lolli I, Bennicelli E, Bini P, Cuccu AS, Scoccianti S, Padovan M, Gori S, Bonetti A, Giordano P, Pellerino A, Gregucci F, Riva N, Cinieri S, Internò V, Santoni M, Pernice G, Dealis C, Stievano L, Paiar F, Magni G, De Salvo GL, Zagonel V, Lombardi G. Caccese M, et al. Among authors: caserta c. ESMO Open. 2024 Apr;9(4):102943. doi: 10.1016/j.esmoop.2024.102943. Epub 2024 Mar 15. ESMO Open. 2024. PMID: 38492275 Free PMC article.
103 results